Biotech Values

[ilpapa]

The Telegraph is giddy (not necessarily a reco)

Scientists said they were amazed to find that patients treated with the highest dose of the antibody drug aducanumab experienced an almost complete clearance of the amyloid plaques that prevent brain cells communicating, leading to irreversible memory loss and cognitive decline.
"These findings could be a 'game changer' if the effects on memory decline can be confirmed in more extensive follow-on studies"David Allsop, Professor of Neuroscience, University of Lancaster

Crucially they also found that after six months of the treatment, patients stopped deteriorating compared with those taking a placebo, suggesting that their dementia had been halted.